Apotex
Encyclopedia
Apotex is a Canadian
pharmaceutical corporation. Founded in 1974, the company is the largest producer of generic drug
s in Canada, with sales exceeding one billion dollars (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4000 dosages, exporting to over 115 countries around the globe.
The company has two main divisions: medical research and development; and biotechnology. The biotechnology division is divided into three subsidiaries.
Apotex owns 61% of Cangene Corp., a Winnipeg
-based biopharmaceutical company, according to Cangene's 2007 annual report. Cangene's business focuses are hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense against infectious diseases such as smallpox, hepatitis B and anthrax. Its products include WinRho SDF.
Apotex has tied up with an Indian biopharmaceutical company, Intas Biopharmaceuticals
, in April 2008 for developing generic version of Filgrastim
for US, Canadian and European market.
In 1991, Apotex opened Apotex Fermentation in Winnipeg to develop fermentation-based
technologies for the production of Active Pharmaceutical Ingredients (APIs) and to manufacture APIs for eventual sale as final dosage forms in Canada and internationally. The factory employs 150 people.
In January 2004, ApoPharma was founded.
Bernard (Barry) Sherman
is the chairman and CEO and Jack M. Kay is the President.
Apotex was recently warned by FDA for GMP issues (May 2010).
See the Link here: http://fdanews.com/newsletter/article?issueId=13736&articleId=127459
Canada
Canada is a North American country consisting of ten provinces and three territories. Located in the northern part of the continent, it extends from the Atlantic Ocean in the east to the Pacific Ocean in the west, and northward into the Arctic Ocean...
pharmaceutical corporation. Founded in 1974, the company is the largest producer of generic drug
Generic drug
A generic drug is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended use." It has also been defined as a term referring to any drug marketed under its...
s in Canada, with sales exceeding one billion dollars (CAD) a year. The company produces more than 300 generic pharmaceuticals in approximately 4000 dosages, exporting to over 115 countries around the globe.
The company has two main divisions: medical research and development; and biotechnology. The biotechnology division is divided into three subsidiaries.
Apotex owns 61% of Cangene Corp., a Winnipeg
Winnipeg
Winnipeg is the capital and largest city of Manitoba, Canada, and is the primary municipality of the Winnipeg Capital Region, with more than half of Manitoba's population. It is located near the longitudinal centre of North America, at the confluence of the Red and Assiniboine Rivers .The name...
-based biopharmaceutical company, according to Cangene's 2007 annual report. Cangene's business focuses are hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense against infectious diseases such as smallpox, hepatitis B and anthrax. Its products include WinRho SDF.
Apotex has tied up with an Indian biopharmaceutical company, Intas Biopharmaceuticals
Intas Biopharmaceuticals
Intas Biopharmaceuticals Ltd. is an Indian biotechnology company headquartered in Ahmedabad, India. Located in the Moraiya,Ahmedabad,it is one of the leading biosimilar product manufacturer in Asia....
, in April 2008 for developing generic version of Filgrastim
Filgrastim
Filgrastim is a granulocyte colony-stimulating factor analog used to stimulate the proliferation and differentiation of granulocytes. It is produced by recombinant DNA technology. The gene for human granulocyte colony-stimulating factor is inserted into the genetic material of Escherichia coli. ...
for US, Canadian and European market.
In 1991, Apotex opened Apotex Fermentation in Winnipeg to develop fermentation-based
technologies for the production of Active Pharmaceutical Ingredients (APIs) and to manufacture APIs for eventual sale as final dosage forms in Canada and internationally. The factory employs 150 people.
In January 2004, ApoPharma was founded.
Bernard (Barry) Sherman
Bernard Sherman
Bernard C. Sherman , Chairman and CEO of Apotex Inc., is a Canadian businessman. With an estimated net worth of $US 2.9 billion , Sherman was ranked by Forbes as the 9th wealthiest Canadian and 393rd in the world....
is the chairman and CEO and Jack M. Kay is the President.
Apotex was recently warned by FDA for GMP issues (May 2010).
See the Link here: http://fdanews.com/newsletter/article?issueId=13736&articleId=127459